Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

Event-Driven

<p>Samsung Heavy Industries is said to have decided to keep the rights offering to less than ₩1tril (US$908mil), and more importantly, Samsung Heavy won’t allocate a portion to be bought by Samsung Group heir apparent Jae-yong Lee as personal bailout. The rights offering won’t be more than 50% of its 230 million shares already in circulation. Assuming the new rights offering of 50% of its 230 million shares at its stock price ended at ₩9,890 on August 16 with 15% discount (which is the same…</p>

Samsung Heavy Industries is said to have decided to keep the rights offering to less than ₩1tril (US$908mil), and more importantly, Samsung Heavy won’t allocate a portion to be bought by Samsung Group heir apparent Jae-yong Lee as personal bailout. The rights offering won’t be more than 50% of its 230 million shares already in circulation. Assuming the new rights offering of 50% of its 230 million shares at its stock price ended at ₩9,890 on August 16 with 15% discount (which is the same…

Update on Samsung Heavy's Rights Offering: Smaller Size than Expected Creates Positive Sentiment

Equity Capital Markets

Samsung Biologics   / Equity Capital Markets

<p>Samsung BioLogics, Samsung Group's contract manufacturing organization (CMO) of bio logic drugs, is expected to seek preliminary approval from Korea Exchange on Thursday this week in an effort to go public on the main KOSPI market.</p><p>It is currently the world's third-largest producer of biomedicines. Its annual production capacity is 180,000 liters, only behind Lonza (240,000 liters) and Boehringer Ingelheim (210,000 liters). Samsung BioLogics plans to use IPO money for expanding its annual…</p>

Samsung BioLogics, Samsung Group's contract manufacturing organization (CMO) of bio logic drugs, is expected to seek preliminary approval from Korea Exchange on Thursday this week in an effort to go public on the main KOSPI market.It is currently the world's third-largest producer of biomedicines. Its annual production capacity is 180,000 liters, only behind Lonza (240,000 liters) and Boehringer Ingelheim (210,000 liters). Samsung BioLogics plans to use IPO money for expanding its annual…

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Thematic (Sector/Industry)

<p><strong>The "One-Shot Act" (also called The Special Act on the Corporate Revitalization) effectively started in Korea on 16 August when <a href="https://www.smartkarma.com/entities/8656" target="_blank" data-smartkarma-citation="entities:8656:1">Hanwha Chemical Corp (009830 KS)</a> became the first company to proactively file its application.</strong> The One-Shot Act was passed into law in February 2016. The One-Shot Act will help companies to accelerate spin-offs and mergers through simplified structures as well as provide tax benefits and subsidies for R&amp;D. The companies that want to benefit from the One-Shot Act need to…</p>

The "One-Shot Act" (also called The Special Act on the Corporate Revitalization) effectively started in Korea on 16 August when Hanwha Chemical Corp (009830 KS) became the first company to proactively file its application. The One-Shot Act was passed into law in February 2016. The One-Shot Act will help companies to accelerate spin-offs and mergers through simplified structures as well as provide tax benefits and subsidies for R&amp;D. The companies that want to benefit from the One-Shot Act need to…

Start of One-Shot Act - The Good, Bad, and the Ugly

Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Equity Bottom-Up

Taiwan Semiconductor (TSMC) / Equity Bottom-Up

<ul><li class="p1">At the Intel Developer Forum in San Francisco, Intel announced a flurry of news with far-reaching implications across the semiconductor landscape.</li><li class="p1">The most important announcement for Intel, in our view, is that the chip leader will be licensing technology from ARM Holdings to offer foundry customers access to ARM physical intellectual property at the 10-nanometer process node.</li><li class="p1">We note that this will allow Intel to compete with Taiwan Semiconductor Manufacturing and Samsung foundries for the business of the likes of Qualcomm and Apple.</li></ul><p class="p1"><em>Analyst: Abhinav Davuluri</em></p>

At the Intel Developer Forum in San Francisco, Intel announced a flurry of news with far-reaching implications across the semiconductor landscape.The most important announcement for Intel, in our view, is that the chip leader will be licensing technology from ARM Holdings to offer foundry customers access to ARM physical intellectual property at the 10-nanometer process node.We note that this will allow Intel to compete with Taiwan Semiconductor Manufacturing and Samsung foundries for the business of the likes of Qualcomm and Apple.Analyst: Abhinav Davuluri

Intel Announces Foundry Collaboration With ARM at Intel Developer Forum

Asia and Global Semiconductor and Tech Research

Andrew Lu

<h2>What's new?</h2><p>Announced at the Intel Developer Forum yesterday, Intel is licensing ARM's 64bit physical CPU core in order to win more foundry customers on 10nm process and announced that LG will use Intel's foundry business to manufacture 10nm smartphone application processor.</p><h2>Negative news to TSMC?</h2><p>Of course, this news is incremental negative to TSMC especially after 28% ytd performance on share price vs. Taiwan Weighted Index' 13% ytd. Two key incremental negatives are: 1) Intel has not given up…</p>

What's new?Announced at the Intel Developer Forum yesterday, Intel is licensing ARM's 64bit physical CPU core in order to win more foundry customers on 10nm process and announced that LG will use Intel's foundry business to manufacture 10nm smartphone application processor.Negative news to TSMC?Of course, this news is incremental negative to TSMC especially after 28% ytd performance on share price vs. Taiwan Weighted Index' 13% ytd. Two key incremental negatives are: 1) Intel has not given up…

Intel Licenses 64bit ARM to Boost Foundry

South Korea

Samsung Electronics Co., Ltd. manufactures a wide range of consumer and industrial electronic equipment and products such as semiconductors, personal computers, peripherals, monitors, televisions, and home appliances including air conditioners and microwave ovens. The Company also produces Internet access network systems and telecommunications equipment including mobile phones.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Samsung Electronics (005930 KS)

Update on Samsung Heavy's Rights Offering: Smaller Size than Expected Creates Positive Sentiment

Samsung Heavy Industries is said to have decided to keep the rights offering to less than ₩1tril (US$908mil), and more importantly, Samsung Heavy...

Sanghyun Park

Samsung BioLogics IPO Valuation Debate

Samsung BioLogics, Samsung Group's contract manufacturing organization (CMO) of bio logic drugs, is expected to seek preliminary approval from...

Sanghyun Park

Start of One-Shot Act - The Good, Bad, and the Ugly

The "One-Shot Act" (also called The Special Act on the Corporate Revitalization) effectively started in Korea on 16 August when Hanwha Chemical...

Douglas Kim

Intel Announces Foundry Collaboration With ARM at Intel Developer Forum

At the Intel Developer Forum in San Francisco, Intel announced a flurry of news with far-reaching implications across the semiconductor...

Morningstar, Inc.

Intel Licenses 64bit ARM to Boost Foundry

What's new?Announced at the Intel Developer Forum yesterday, Intel is licensing ARM's 64bit physical CPU core in order to win more foundry...

Andrew Lu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)